Onderneming RedHill Biopharma Ltd. OTC Markets
Aandelen
REDIF
IL0011223810
Farmaceutische producten
Vakgebied
Aantal werknemers: 53
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Commercial
100,0
%
| 62 | 100,0 % | 7 | 100,0 % | -89,43% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 62 | 100,0 % | 7 | 100,0 % | -89,43% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 03-08-09 |
Ori Shilo
FOU | Founder | 58 | 03-08-09 |
Razi Ingber
DFI | Director of Finance/CFO | - | 05-01-23 |
Gilead Raday
COO | Chief Operating Officer | 49 | 10-11-10 |
Ira N. Kalfus
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Reza Fathi
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-05-10 |
kristin Comer
CMP | Compliance Officer | - | - |
June Almenoff
CTO | Chief Tech/Sci/R&D Officer | 67 | 28-05-19 |
Mark L. Levitt
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Terry F. Plasse
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 01-01-16 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 26-08-10 |
Director/Board Member | 80 | 03-05-10 | |
Alla Felder
BRD | Director/Board Member | 51 | 06-05-19 |
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 03-08-09 |
Kenneth Reed
BRD | Director/Board Member | 70 | 15-12-09 |
Ofer Tsimchi
BRD | Director/Board Member | 64 | 04-05-11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 7 869 853 000 | 7 791 154 470 ( 99,00 %) | 0 | 99,00 % |
Bedrijfsgegevens
![Adres RedHill Biopharma Ltd.(REDIF)](https://cdn.zonebourse.com/static/address/120794093.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,73% | 100 mld. | |
+8,42% | 42,34 mld. | |
-13,04% | 32,76 mld. | |
+80,80% | 29,46 mld. | |
-10,92% | 16,31 mld. | |
+1,93% | 14,39 mld. | |
-6,77% | 12,23 mld. | |
+177,16% | 10,47 mld. | |
+4,12% | 8,97 mld. |